IFF · 8-K · 20260804PR000028

Segment Profitability

INTERNATIONAL FLAVORS & FRAGRANCES INC · 2026-08-04 · Importance 42 · Surprise 14 · No source text

Second-quarter 2026 currency-neutral adjusted operating EBITDA increased 6% for the consolidated company, with segment growth of 6% in Taste, 6% in Health & Biosciences, and 5% in Scent. Reported segment adjusted operating EBITDA was $122 million in Taste, $146 million in Health & Biosciences, and $126 million in Scent, producing a consolidated $394 million. Second-quarter adjusted EBITDA margins were 18.0% in Taste, 24.9% in Health & Biosciences, and 19.4% in Scent, while consolidated margin was 20.6%. For the six months ended June 30, 2026, currency-neutral EBITDA rose 14% in Taste, 8% in Health & Biosciences, and 2% in Scent, with consolidated growth of 8%.

Key facts

• Inclusive of discontinued operations adjusted operating EBITDA of $140 million, adjusted operating EBITDA for the second quarter was $548 million. source
• Second quarter adjusted (Non-GAAP) Operating EBITDA was $408 M and Operating EBITDA Margin was 20.9% on a continuing operations basis. source
• First six months 2026 adjusted operating EBITDA was $841 M and adjusted EPS ex amortization was $1.74. source
• On a continuing operations basis, the Company delivered second quarter 2026 Adjusted Operating EBITDA margin of 20.9%, an improvement compared to 19.7% including discontinued operations. source
• Reported net income attributable to IFF shareholders for the three months ended June 30, 2026 was $50 million compared to $599 million in the prior year period. source
• Second quarter comparable currency neutral adjusted operating EBITDA growth by segment: Taste 6%, Health & Biosciences 6%, Scent 5%, Consolidated 6%. source
• Six months ended June 30, 2026 Total segment adjusted operating EBITDA: $803 million. source
• Q2 2026 Total segment adjusted operating EBITDA: $394 million. source

Impact estimates